相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
Therapeutic antibodies against CGRP or its receptor
Marcelo E. Bigal et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The therapeutic armamentarium in migraine is quite elderly
Paolo Martelletti
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
Marcelo E. Bigal et al.
CNS DRUGS (2014)
The Vasodilatory Activity of CGRP: A Response
Marcelo E. Bigal et al.
HEADACHE (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
Sarah Walter et al.
MABS (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
Therapeutic Prospects for Migraine: Can Paradise Be Regained?
Peter J. Goadsby
ANNALS OF NEUROLOGY (2013)
CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
C. S. Walker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Localization of CGRP Receptor Components, CGRP, and Receptor Binding Sites in Human and Rhesus Cerebellar Cortex
Sajedeh Eftekhari et al.
CEREBELLUM (2013)
Evolution and Emergence of Therapeutic Monoclonal Antibodies What Cardiologists Need to Know
Ian N. Foltz et al.
CIRCULATION (2013)
Emerging Target-Based Paradigms to Prevent and Treat Migraine
S. D. Silberstein
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
Sajedeh Eftekhari et al.
JOURNAL OF PAIN (2013)
In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232
Eric D. Hostetler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes
R. J. Bailey et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
Tony W. Ho et al.
HEADACHE (2012)
Direct optic nerve pulvinar connections defined by diffusion MR tractography in humans: Implications for photophobia
Nasim Maleki et al.
HUMAN BRAIN MAPPING (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat
Benoit Michot et al.
PAIN (2012)
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression
Alessandro Tozzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Activation of Central Trigeminovascular Neurons by Cortical Spreading Depression
XiChun Zhang et al.
ANNALS OF NEUROLOGY (2011)
Refractory migraine in a headache clinic population
Pablo Irimia et al.
BMC NEUROLOGY (2011)
Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level
Sajedeh Eftekhari et al.
BMC NEUROSCIENCE (2011)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Advances in understanding the mechanisms of migraine-type photophobia
Rodrigo Noseda et al.
CURRENT OPINION IN NEUROLOGY (2011)
Acute Migraine Therapy: New Drugs and New Approaches
Teshamae S. Monteith et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
Ann C. Raddant et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Antimigraine Efficacy of Telcagepant Based on Patient's Historical Triptan Response
Tony W. Ho et al.
HEADACHE (2011)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine
Paul L. Durham et al.
CNS DRUGS (2010)
Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura
XiChun Zhang et al.
JOURNAL OF NEUROSCIENCE (2010)
A neural mechanism for exacerbation of headache by light
Rodrigo Noseda et al.
NATURE NEUROSCIENCE (2010)
CGRP and its receptors provide new insights into migraine pathophysiology
Tony W. Ho et al.
NATURE REVIEWS NEUROLOGY (2010)
Crystal Structure of the Ectodomain Complex of the CGRP Receptor, a Class-B GPCR, Reveals the Site of Drug Antagonism
Ernst ter Haar et al.
STRUCTURE (2010)
Regulation of signal transduction by calcitonin gene-related peptide receptors
Christopher S. Walker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
αCGRP and βCGRP transcript amount in mouse tissues of various developmental stages and their tissue expression sites
Abdol Hossein Rezaeian et al.
BRAIN & DEVELOPMENT (2009)
Effect of adrenomedullin on the cerebral circulation: relevance to primary headache disorders
K. A. Petersen et al.
CEPHALALGIA (2009)
Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache
M. De Felice et al.
CEPHALALGIA (2009)
Migraine in the Triptan Era: Lessons From Epidemiology, Pathophysiology, and Clinical Science
Marcelo E. Bigal et al.
HEADACHE (2009)
Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan
Roger K. Cady et al.
HEADACHE (2009)
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
Ana Recober et al.
JOURNAL OF NEUROSCIENCE (2009)
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
J. Zeller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Synthesis of the (3R,6S)-3-amino-6-(2,3-difluorophenyl)azepan-2-one of telcagepant (MK-0974), a calcitonin gene-related peptide receptor antagonist for the treatment of migraine headache
Christopher S. Burgey et al.
ORGANIC LETTERS (2008)
International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2008)
Crystal structure of the human receptor activity-modifying protein 1 extracellular domain
Seisuke Kusano et al.
PROTEIN SCIENCE (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
L. Edvinsson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Calcitonin receptor-like and receptor activity modifying protein 1 in the rat dorsal horn localization in glutamatergic presynaptic terminal containing opioids and adrenergic α2c receptor
J. C. G. Marvizon et al.
NEUROSCIENCE (2007)
Evolution of the CT/CGRP family: Comparative study with new data from models of teleosts, the eel, and cephalopod molluscs, the cuttlefish and the nautilus
Anne-Gaelle Lafont et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2007)
Neuron-glia signaling in trigeminal ganglion: Implications for migraine pathology
Srikanth Thalakoti et al.
HEADACHE (2007)
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion
Zhongming Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead
TM Williams et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Unitary hypothesis for multiple triggers of the pain and strain of migraine
R Burstein et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
DL Hay et al.
MOLECULAR PHARMACOLOGY (2005)
Cortical spreading depression activates and upregulates MMP-9
Y Gursoy-Ozdemir et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Calcitonin gene-related peptide and its role in migraine pathophysiology
U Arulmani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache
L Edvinsson
CEPHALALGIA (2004)
Cardiovascular risk assessment and triptans
V Papademetriou
HEADACHE (2004)
Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression
SG Rossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs
EA Schulman et al.
HEADACHE (2003)
Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity
C Yallampalli et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Interaction of calcitonin-gene-related peptide with its receptors
AC Conner et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
DR Poyner et al.
PHARMACOLOGICAL REVIEWS (2002)
Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists
JJ Mallee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists
KJ Powell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor
MJ Coloma et al.
PHARMACEUTICAL RESEARCH (2000)
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
